Last updated: February 25, 2026
Sponsor: University of Pennsylvania
Overall Status: Active - Recruiting
Phase
N/A
Condition
Sickle Cell Disease
Red Blood Cell Disorders
Treatment
Stress Management and Mindfulness Intervention for Patients with Sickle Cell Disease
Clinical Study ID
NCT07316478
859513
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18 years of age or older.
Diagnosed with sickle cell disease.
Live within 90 minutes of Philadelphia
Exclusion
Exclusion Criteria:
- Severe depression or suicidality
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Stress Management and Mindfulness Intervention for Patients with Sickle Cell Disease
Phase:
Study Start date:
January 15, 2026
Estimated Completion Date:
December 30, 2026
Study Description
Connect with a study center
University of Pennsylvania
Philadelphia 4560349, Pennsylvania 6254927 19104
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.